Pharmacogenetics in the Treatment of Pre-Eclampsia: Current Findings, Challenges and Perspectives
Pre-eclampsia (PE) is defined as pregnancy-induced hypertension and proteinuria, and is a major cause of maternal and perinatal morbidity and mortality. A large subgroup of pregnant women with PE is nonresponsive to antihypertensive drugs, including methyldopa, nifedipine and hydralazine. Pharmacoge...
Saved in:
| Main Authors: | , , , |
|---|---|
| 格式: | Revisão |
| 語言: | 英语 |
| 出版: |
2017
|
| 在線閱讀: | https://doi.org/10.2217/pgs-2016-0198 https://www.futuremedicine.com/doi/pdf/10.2217/pgs-2016-0198 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|